Sanzyme Biologics (founded as Uni-Sankyo in the year 1969) is a
pioneer in fermentation technology with 50 years of legacy in the area of
probiotics. It was the first company to manufacture and sell
probiotics in India and today a market leader with presence in over 40
countries across the globe including key markets such as US, Europe, Japan,
South Korea, Australia, New Zealand, China and Taiwan.
Sanzyme Biologics manufactures aerobic spore formers (Bacillus coagulans SNZ 1969®, Bacillus clausii SNZ 1971™, and Bacillus subtilis SNZ 1972™), aerobic vegetative strains (lactobacillus spp. etc.) and yeast (Saccharomyces boulardii SNZ 1986™) in its world class facility at Hyderabad, India. It adopts proprietary technology and has a sound selection of strains meeting global standards.
Flagship strain Bacillus coagulans SNZ 1969® is an aerobic spore-forming, lactic acid-producing probiotic bacteria. SNZ 1969® spores are robust and offers flexibility to food, supplement, and pharma product formulators. It sustains processing conditions, gut pH, bile salt and does not require cold chain unlike vegetative probiotic strains. It has US FDA GRAS (including infants), Health Canada approval, non-GMO project verified and supported with 30 plus scientific pub...
|Primary business activity||Manufacturer: Ingredients / Additives|
|Affiliated categories:||Contract manufacturing |Contract Research |Enzymes More|